This year, the KassenGipfel 2022, organized by MCC, will take place as both an in-person (Berlin) and online event. We are pleased to be part of the program on September 28 and 29 with the EIT Health Roundtable Discussion.
Within the framework of the KassenGipfel 2022, FUTURE PROOFING MEDICINES will take place as a satellite event moderated by Carlos Härtel, the Chairman of the Board of Directors at Science|Business.
The September 28/29 meeting in Berlin is an opportunity for German health sector leaders to present their views on the future of medicines regulation, its potential impact on industry and society, and how the power of medical science, health data and digital innovation can be fully harnessed in the years to come. It will be the second high-level meeting of the Future Proofing Medicines initiative, bridging between an expert roundtable in Copenhagen (June 2022) and a public conference in Stockholm (Q1 2023) during the Swedish Presidency of the European Council.
Economic and financial environment/capitalization and financing of healthcare services
Political, legal, fiscal and regulatory framework conditions
The resilience and innovative capacity of the German healthcare system put to the test
Sustainability in healthcare: Green Healthcare Health DIGITAL – 2025
Head of the New Technologies and Data Use, BMG
Prof. Freimut Schliess
Member of the Supervisory Board, EIT Health
Chief Medical Officer & Managing Director, heartbeat medical
Dr. Christoph Löschmann
Chairman of the Board, Gesundes Kinzigtal GmbH
Dr. Michael Alain Lüttgen
Stakeholder Relations Lead, EIT Health Germany GmbH
Prof. Dr. Dr. Alexander P. F. Ehlers
Specialist in medical law, specialist in general medicine, Ehlers & Partner
Dr. Katharina Ladewig
Managing Director Centre for AI, RKI